CRE 223

Also Known As:

2,6-dimethyl-5-methoxycarbonyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate-2-tetrahydrofurfuryl; CRE-223; 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl (tetrahydro-2-furanyl)methyl ester

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Dihydropyridines: 214
      - CRE 223: 1

Related Diseases

1.	Thrombosis (Thrombus) 06/03/1987 - "The dihydropyridine agents, CRE-223 and Nifedipine, were highly protective against experimental thrombosis, whereas Verapamil had a weaker and much shorter effect and, on the other hand, Diltiazem had no protective effect over a range of doses. "

Related Drugs and Biologics

1.	Verapamil (Calan)
2.	Nifedipine (Adalat)
3.	Diltiazem (Cardizem)
4.	1,4-dihydropyridine (dihydropyridine)